Clinical Trials

Cancer

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 50 of 149 Clinical Trials Related to Cancer

Clinical Research Trial

NRG BN007

A Randomized Phase II/III Open-label Study of Ipilimumab and Nivolumab vs Temozolomide in Patients with Newly Diagnosed MGMT Unmethylated Glioblastoma

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

A011801 Breast Cancer

THE COMPASSHER2 TRIALS (COMPREHENSIVE USE OF PATHOLOGIC RESPONSE ASSESSMENT TO OPTIMIZE THERAPY IN HER2-POSITIVE BREAST CANCER): COMPASSHER2 RESIDUAL DISEASE (RD), A DOUBLE-BLINDED, PHASE III RANDOMIZED TRIAL OF T-DM1 AND PLACEBO

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

Swog 1826 Hodgkin Lymphoma

A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

A081801 Lung Cancer

INTEGRATION OF IMMUNOTHERAPY INTO ADJUVANT THERAPY FOR RESECTED NSCLC: ALCHEMIST CHEMO-IO (ACCIO)

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

EA5191 Non-Squamous NSCLC

A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus Nivolumab Versus Standard Chemotherapy in Patients with Previously Treated Non-Squamous NSCLC

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

SWOG S1900E

A Phase II Study of AMG 510 in Participants With Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous Non-Small Cell Lung Cancer (ECOG-ACRIN LUNG-MAP SUB-STUDY)

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

A051701 Lymphoma

RANDOMIZED PHASE II/III STUDY OF VENETOCLAX (ABT 199) PLUS CHEMOIMMUNOTHERAPY FOR MYC/BCL2 DOUBLE-HIT AND DOUBLE EXPRESSING LYMPHOMAS

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

MSK 20-067 Endometrial Cancer

SEntinel Lymph node Endometrial Cancer Trial: A Prospective Multicenter International Single-Arm Observational Trial(SELECT)